All In Biotech

Drug Trial Radar · NCT07052942

Individualizing Treatment for Asthma in Primary Care (Full Study)

Last checked: Nov 19, 2026Latest source record: Oct 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 3,200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

3,200

Planned (sponsor's estimate)

Start

Aug 1, 2025

Primary completion

Nov 15, 2029

Study completion Nov 15, 2029

Sponsor

Lead sponsor
DARTNet InstituteGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
Penn State University; Icahn School of Medicine at Mount Sinai; University of Colorado, Denver; RAND; University of Washington; University of North Carolina; Reliant Medical Group; Kelsey Research Foundation; University of Kansas; University of Missouri-Columbia; John Peter Smith Health Network; Rutgers University; AdventHealth; Wake Forest University Health Sciences
First posted
Jul 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 13 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects. This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be called Rescue-Inhaled Corticosteroids or R-ICS pronounced "Ricks," and (2) use of azithromycin (AZ) as a preventive therapy. These treatments will be studied both individually and in combination.

Conditions

  • Asthma
  • Asthma Attack
  • Asthma Exacerbations

Interventions

  • Inhaled corticosteroid (ICS)Drug

    Participants will use either a combination of budesonide/formoterol or mometasone/formoterol as both controller and rescue therapy or a stand alone inhaled steroid (beclomethasone, budesonide, fluticasone, mometasone, ciclesodine) of their choice with their current reliever therapy or be converted to budesonide/albuterol as rescue therapy.

  • AzithromycinDrug

    Participants will take 500mg of azithromycin three times a week or 10mg/kg if under 50Kg which may be reduced to 250mg/Kg for side effects.

  • Asthma Symptom Monitoring Web-based ApplicationOther

    All participants will be provided access to the Asthma Symptom Monitoring (ASM) tools. ASM can be integrated with electronic health records (EHR) or used as a stand alone application. Participants will answer 5 questions about their asthma each week. If symptoms are problematic, participants can request a call back from a person on their care team. Participants can view a graph of their data, watch videos, and record peak flows. Clinicians and members of the care team can view data in the EHR (not for stand alone web app).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Asthma Exacerbations Per YearTime frame: Follow-up is up to 16 months.

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • DARTNet Institute

    Aurora, Colorado · Recruiting

  • University Colorado-Denver

    Aurora, Colorado · Recruiting

  • AdventHealth

    Orlando, Florida · Not yet recruiting

  • University of Kansas

    Kansas City, Kansas · Not yet recruiting

  • Reliant Medical Group

    Worcester, Massachusetts · Recruiting

  • University of Missouri

    Columbia, Missouri · Not yet recruiting

  • Rutgers Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Recruiting

  • Mt. Sinai School of Medicine

    New York, New York · Recruiting

  • University North Carolina

    Chapel Hill, North Carolina · Recruiting

  • Atrium Health

    Charlotte, North Carolina · Recruiting

  • JPS Health Network

    Fort Worth, Texas · Not yet recruiting

  • Kelsey Research Foundation

    Houston, Texas · Recruiting

  • University of Washington

    Seattle, Washington · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.